Package 76420-546-90

{"route": ["ORAL"], "spl_id": "17d94690-32d0-14b1-e063-6294a90ae902", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["403957"], "spl_set_id": ["101f44e4-669c-4e3d-843a-a27157750f9c"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-546-30)", "package_ndc": "76420-546-30", "marketing_start_date": "20230328"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-546-60)", "package_ndc": "76420-546-60", "marketing_start_date": "20230328"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-546-90)", "package_ndc": "76420-546-90", "marketing_start_date": "20230328"}], "brand_name": "TADALAFIL", "product_id": "76420-546_17d94690-32d0-14b1-e063-6294a90ae902", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "76420-546", "generic_name": "TADALAFIL", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TADALAFIL", "active_ingredients": [{"name": "TADALAFIL", "strength": "5 mg/1"}], "application_number": "ANDA211839", "marketing_category": "ANDA", "marketing_start_date": "20190326", "listing_expiration_date": "20261231"}